ИДЕАЛЬНАЯ ДОЗА АЦЕТИЛСАЛИЦИЛОВОЙ КИСЛОТЫ ДЛЯ ПРИМЕНЕНИЯ В КАРДИОЛОГИИ – ПОИСК ЗАВЕРШЕН?

1. Buerke M, Pittroff W, Meyer J, et al. Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses// AmHeart J. 1995;130:465-472.

2. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects//J Clin Invest. 1982;69:1366-1372.

3. Dabaghi SF, Kamat SG, Payne J, et al. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects//Am J Cardiol. 1994;74:720-723.

4. Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition//Circulation. 1985;72:177-184

5. Montalescot G, Maclouf J, Drobinski G, et al. Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin// J Am Coll Cardiol. 1994;24:33-38.

6. Montalescot G, Drobinski G, Maclouf J, et al. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris// Circulation. 1991;84:2054-2062.

7. Ridker PM, Hennekens CH, Tofler GH, et al. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebocontrolled trial of regular and enteric coated formulations in men and women//J Cardiovasc Risk. 1996; 3:209-212.

8. Gurbel P.A, Bliden K.P, DiChiara J. et al. Evaluation of Dose-related effects of aspirin on platelet function. Results from the Aspirin[Induced Platelet Effect (ASPECT) Study//Circulation 2007; 115: 3156-3164

9. Farrell B, Godwin J, Richards S, et al. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results//J Neurol Neurosurg Psychiatry. 1991;54:1044 –1054.

10. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke//N Engl J Med. 1991;325:1261– 1266.

11. Taylor DW, Barnett HJ, Haynes RB et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial//ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999;353:2179–2184.

12. Lee TK, Lien IN, Ryu SJ, et al. Secondary prevention of ischemic stroke with low dose acetylsalicylic acid// J Formos Med Assoc. 1990;89:635-644.

13. Hoffman W, Forster W. Two year Cottbus reinfarction study with 30 mg aspirin per day // Prostaglandins Leukot Essent Fatty Acids. 1991;44:159-169.

14. O’Connor CM, Meese RB, McNulty S, et al; DUCCS-II Investigators. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction//Am J Cardiol. 1996;77:791-797.

15. Minar E, Ahmadi A, Koppensteiner R, et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty//Circulation. 1995;91:2167-2173.

16. The CURRENT-OASIS Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes//N Engl J Med 2010; 363:930-942.

17. Mehta S., Bassnd J.-P., Chrolavicus S. et al on behalf of the CURRENT-OASIS7 committee. Design and rationale of CURRENT-OASIS7: A randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST elevation acute coronary syndromes managed with an early invasive strategy // Am Heart J 2008; 156: 1080-1088

18. С остальными литературными источниками (18-33) можно ознакомиться – cardio.nauka@yandex.ru